Logo image of DAN.CA

ARIANNE PHOSPHATE INC (DAN.CA) Stock Fundamental Analysis

TSX-V:DAN - TSX Venture Exchange - CA04035D1024 - Common Stock - Currency: CAD

0.135  0 (0%)

Fundamental Rating

1

Overall DAN gets a fundamental rating of 1 out of 10. We evaluated DAN against 818 industry peers in the Metals & Mining industry. DAN has a bad profitability rating. Also its financial health evaluation is rather negative. DAN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DAN had negative earnings in the past year.
In the past year DAN has reported a negative cash flow from operations.
In the past 5 years DAN always reported negative net income.
DAN had a negative operating cash flow in each of the past 5 years.
DAN.CA Yearly Net Income VS EBIT VS OCF VS FCFDAN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -13.69%, DAN perfoms like the industry average, outperforming 53.67% of the companies in the same industry.
DAN has a Return On Equity of -27.88%. This is comparable to the rest of the industry: DAN outperforms 51.06% of its industry peers.
Industry RankSector Rank
ROA -13.69%
ROE -27.88%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DAN.CA Yearly ROA, ROE, ROICDAN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5 -10 -15 -20

1.3 Margins

DAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DAN.CA Yearly Profit, Operating, Gross MarginsDAN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for DAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DAN.CA Yearly Shares OutstandingDAN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
DAN.CA Yearly Total Debt VS Total AssetsDAN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

DAN has an Altman-Z score of -1.38. This is a bad value and indicates that DAN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.38, DAN is in line with its industry, outperforming 41.72% of the companies in the same industry.
DAN has a Debt/Equity ratio of 0.85. This is a neutral value indicating DAN is somewhat dependend on debt financing.
DAN has a Debt to Equity ratio of 0.85. This is in the lower half of the industry: DAN underperforms 74.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z -1.38
ROIC/WACCN/A
WACCN/A
DAN.CA Yearly LT Debt VS Equity VS FCFDAN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 0.75 indicates that DAN may have some problems paying its short term obligations.
The Current ratio of DAN (0.75) is worse than 63.26% of its industry peers.
A Quick Ratio of 0.75 indicates that DAN may have some problems paying its short term obligations.
DAN has a worse Quick ratio (0.75) than 61.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
DAN.CA Yearly Current Assets VS Current LiabilitesDAN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DAN have decreased strongly by -10.53% in the last year.
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DAN.CA Yearly EPS VS EstimatesDAN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 -0.02 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DAN.CA Price Earnings VS Forward Price EarningsDAN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DAN.CA Per share dataDAN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARIANNE PHOSPHATE INC

TSX-V:DAN (5/9/2025, 7:00:00 PM)

0.135

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-01 2025-05-01
Earnings (Next)05-22 2025-05-22
Inst Owners1.24%
Inst Owner ChangeN/A
Ins Owners3.59%
Ins Owner ChangeN/A
Market Cap27.39M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.69%
ROE -27.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 196.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z -1.38
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)556.61%
Cap/Depr(5y)1136.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.58%
OCF growth 3YN/A
OCF growth 5YN/A